Yüklüyor......
Targeted Therapies and Biomarkers in Small Cell Lung Cancer
Small cell lung cancer (SCLC) is an aggressive malignancy characterized by rapid growth, early metastasis, and acquired therapeutic resistance. A majority of patients with SCLC have extensive-stage (ES) disease, defined as the presence of metastatic disease outside the hemithorax at first diagnosis....
Kaydedildi:
| Yayımlandı: | Front Oncol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7251180/ https://ncbi.nlm.nih.gov/pubmed/32509576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00741 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|